UniProt ID | M3K9_HUMAN | |
---|---|---|
UniProt AC | P80192 | |
Protein Name | Mitogen-activated protein kinase kinase kinase 9 | |
Gene Name | MAP3K9 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1104 | |
Subcellular Localization | ||
Protein Description | Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.. | |
Protein Sequence | MEPSRALLGCLASAAAAAPPGEDGAGAGAEEEEEEEEEAAAAVGPGELGCDAPLPYWTAVFEYEAAGEDELTLRLGDVVEVLSKDSQVSGDEGWWTGQLNQRVGIFPSNYVTPRSAFSSRCQPGGEDPSCYPPIQLLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTIEESGFFEMPKDSFHCLQDNWKHEIQEMFDQLRAKEKELRTWEEELTRAALQQKNQEELLRRREQELAEREIDILERELNIIIHQLCQEKPRVKKRKGKFRKSRLKLKDGNRISLPSDFQHKFTVQASPTMDKRKSLINSRSSPPASPTIIPRLRAIQLTPGESSKTWGRSSVVPKEEGEEEEKRAPKKKGRTWGPGTLGQKELASGDEGSPQRREKANGLSTPSESPHFHLGLKSLVDGYKQWSSSAPNLVKGPRSSPALPGFTSLMEMEDEDSEGPGSGESRLQHSPSQSYLCIPFPRGEDGDGPSSDGIHEEPTPVNSATSTPQLTPTNSLKRGGAHHRRCEVALLGCGAVLAATGLGFDLLEAGKCQLLPLEEPEPPAREEKKRREGLFQRSSRPRRSTSPPSRKLFKKEEPMLLLGDPSASLTLLSLSSISECNSTRSLLRSDSDEIVVYEMPVSPVEAPPLSPCTHNPLVNVRVERFKRDPNQSLTPTHVTLTTPSQPSSHRRTPSDGALKPETLLASRSPSSNGLSPSPGAGMLKTPSPSRDPGEFPRLPDPNVVFPPTPRRWNTQQDSTLERPKTLEFLPRPRPSANRQRLDPWWFVSPSHARSTSPANSSSTETPSNLDSCFASSSSTVEERPGLPALLPFQAGPLPPTERTLLDLDAEGQSQDSTVPLCRAELNTHRPAPYEIQQEFWS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
110 | Phosphorylation | VGIFPSNYVTPRSAF CCEECCCCCCHHHHH | 15.27 | 27642862 | |
118 | Phosphorylation | VTPRSAFSSRCQPGG CCHHHHHHCCCCCCC | 19.31 | 24719451 | |
193 | Ubiquitination | ENVRQEAKLFAMLKH HHHHHHHHHHHHHHC | 43.30 | - | |
304 | Phosphorylation | LAREWHRTTKMSAAG HHHHHHHCCCCCCCC | 20.20 | 15610029 | |
305 | Phosphorylation | AREWHRTTKMSAAGT HHHHHHCCCCCCCCH | 25.38 | 15610029 | |
308 | Phosphorylation | WHRTTKMSAAGTYAW HHHCCCCCCCCHHHH | 19.27 | 15610029 | |
312 | Phosphorylation | TKMSAAGTYAWMAPE CCCCCCCHHHHHCHH | 12.82 | 15610029 | |
452 | Phosphorylation | RTWEEELTRAALQQK HHHHHHHHHHHHHHH | 22.88 | - | |
519 | Phosphorylation | LKDGNRISLPSDFQH CCCCCEECCCCCCCC | 30.87 | 30266825 | |
522 | Phosphorylation | GNRISLPSDFQHKFT CCEECCCCCCCCCEE | 57.24 | 30266825 | |
529 | Phosphorylation | SDFQHKFTVQASPTM CCCCCCEEEEECCCC | 19.26 | 30266825 | |
533 | Phosphorylation | HKFTVQASPTMDKRK CCEEEEECCCCHHHH | 12.10 | 30266825 | |
535 | Phosphorylation | FTVQASPTMDKRKSL EEEEECCCCHHHHHH | 35.19 | 30266825 | |
541 | Phosphorylation | PTMDKRKSLINSRSS CCCHHHHHHHHCCCC | 38.22 | 23090842 | |
545 | Phosphorylation | KRKSLINSRSSPPAS HHHHHHHCCCCCCCC | 26.92 | 23090842 | |
547 | Phosphorylation | KSLINSRSSPPASPT HHHHHCCCCCCCCCC | 47.20 | 30266825 | |
548 | Phosphorylation | SLINSRSSPPASPTI HHHHCCCCCCCCCCC | 33.52 | 30266825 | |
552 | Phosphorylation | SRSSPPASPTIIPRL CCCCCCCCCCCHHHE | 28.49 | 30266825 | |
554 | Phosphorylation | SSPPASPTIIPRLRA CCCCCCCCCHHHEEE | 29.10 | 30266825 | |
565 | Phosphorylation | RLRAIQLTPGESSKT HEEEEECCCCCCCCC | 16.93 | 17192257 | |
576 | Phosphorylation | SSKTWGRSSVVPKEE CCCCCCCCCCCCHHH | 24.44 | 30624053 | |
577 | Phosphorylation | SKTWGRSSVVPKEEG CCCCCCCCCCCHHHC | 26.27 | 30624053 | |
594 | Acetylation | EEKRAPKKKGRTWGP HHHHCCCCCCCCCCC | 60.44 | 7377509 | |
595 | Acetylation | EKRAPKKKGRTWGPG HHHCCCCCCCCCCCC | 60.80 | 7377519 | |
598 | Phosphorylation | APKKKGRTWGPGTLG CCCCCCCCCCCCCCC | 43.36 | 28176443 | |
607 | Acetylation | GPGTLGQKELASGDE CCCCCCHHHHCCCCC | 53.55 | 11922609 | |
616 | Phosphorylation | LASGDEGSPQRREKA HCCCCCCCHHHHHHH | 18.80 | - | |
630 | Phosphorylation | ANGLSTPSESPHFHL HCCCCCCCCCCCCCC | 51.28 | 28450419 | |
632 | Phosphorylation | GLSTPSESPHFHLGL CCCCCCCCCCCCCCH | 28.19 | 28450419 | |
652 | Phosphorylation | GYKQWSSSAPNLVKG HHHHHHCCCCCCCCC | 42.08 | 22617229 | |
658 | Ubiquitination | SSAPNLVKGPRSSPA CCCCCCCCCCCCCCC | 67.38 | - | |
693 | Phosphorylation | GESRLQHSPSQSYLC CCCCCCCCCCCCEEE | 17.18 | 25849741 | |
695 | Phosphorylation | SRLQHSPSQSYLCIP CCCCCCCCCCEEEEE | 34.47 | 28464451 | |
697 | Phosphorylation | LQHSPSQSYLCIPFP CCCCCCCCEEEEECC | 25.14 | 25106551 | |
698 | Phosphorylation | QHSPSQSYLCIPFPR CCCCCCCEEEEECCC | 9.65 | 28464451 | |
707 | Phosphorylation | CIPFPRGEDGDGPSS EEECCCCCCCCCCCC | 61.16 | 24719451 | |
709 | Phosphorylation | PFPRGEDGDGPSSDG ECCCCCCCCCCCCCC | 37.16 | 27251275 | |
807 | Phosphorylation | RSSRPRRSTSPPSRK CCCCCCCCCCCCCHH | 34.22 | 23663014 | |
808 | Phosphorylation | SSRPRRSTSPPSRKL CCCCCCCCCCCCHHH | 43.36 | 23663014 | |
809 | Phosphorylation | SRPRRSTSPPSRKLF CCCCCCCCCCCHHHC | 35.74 | 23663014 | |
812 | Phosphorylation | RRSTSPPSRKLFKKE CCCCCCCCHHHCCCC | 45.49 | 23663014 | |
852 | Phosphorylation | STRSLLRSDSDEIVV CCHHHHHCCCCCEEE | 41.24 | 28348404 | |
854 | Phosphorylation | RSLLRSDSDEIVVYE HHHHHCCCCCEEEEE | 38.09 | 28348404 | |
915 | Phosphorylation | QPSSHRRTPSDGALK CCCCCCCCCCCCCCC | 27.40 | 30266825 | |
917 | Phosphorylation | SSHRRTPSDGALKPE CCCCCCCCCCCCCHH | 48.33 | 30266825 | |
925 | Phosphorylation | DGALKPETLLASRSP CCCCCHHHHCCCCCC | 35.28 | 27251275 | |
929 | Phosphorylation | KPETLLASRSPSSNG CHHHHCCCCCCCCCC | 33.01 | 23927012 | |
931 | Phosphorylation | ETLLASRSPSSNGLS HHHCCCCCCCCCCCC | 27.00 | 19060867 | |
934 | Phosphorylation | LASRSPSSNGLSPSP CCCCCCCCCCCCCCC | 38.00 | 21082442 | |
938 | Phosphorylation | SPSSNGLSPSPGAGM CCCCCCCCCCCCCCC | 25.40 | - | |
948 | Phosphorylation | PGAGMLKTPSPSRDP CCCCCCCCCCCCCCC | 25.66 | - | |
952 | Phosphorylation | MLKTPSPSRDPGEFP CCCCCCCCCCCCCCC | 54.36 | 28258704 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
304 | T | Phosphorylation | Kinase | MAP3K9 | P80192 | GPS |
308 | S | Phosphorylation | Kinase | MAP3K9 | P80192 | GPS |
312 | T | Phosphorylation | Kinase | MAP3K9 | P80192 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | SMURF1 | Q9HCE7 | PMID:20804422 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of M3K9_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HS90A_HUMAN | HSP90AA1 | physical | 22939624 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-529; SER-533; THR-535;SER-547; SER-552; THR-565; SER-652; SER-693; SER-695; THR-915; SER-917AND SER-929, AND MASS SPECTROMETRY. | |
"Phosphoregulation of mixed-lineage kinase 1 activity by multiplephosphorylation in the activation loop."; Durkin J.T., Holskin B.P., Kopec K.K., Reed M.S., Spais C.M.,Steffy B.M., Gessner G., Angeles T.S., Pohl J., Ator M.A., Meyer S.L.; Biochemistry 43:16348-16355(2004). Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION,PHOSPHORYLATION AT THR-304; THR-305; SER-308 AND THR-312, ANDMUTAGENESIS OF LYS-171; THR-304; THR-305; SER-308 AND THR-312. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-565, AND MASSSPECTROMETRY. |